F5, Inc. Operating Cash Flow increased by 129.8% to $365.92M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 42.6%, from $256.60M to $365.92M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 10.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $182.30M | $197.05M | $90.37M | $126.51M | $71.40M | $154.36M | $157.63M | $140.92M | $165.05M | $189.80M | $165.32M | $221.64M | $158.96M | $246.51M | $202.78M | $256.60M | $282.22M | $208.07M | $159.21M | $365.92M |
| QoQ Change | — | +8.1% | -54.1% | +40.0% | -43.6% | +116.2% | +2.1% | -10.6% | +17.1% | +15.0% | -12.9% | +34.1% | -28.3% | +55.1% | -17.7% | +26.5% | +10.0% | -26.3% | -23.5% | +129.8% |
| YoY Change | — | — | — | — | -60.8% | -21.7% | +74.4% | +11.4% | +131.2% | +23.0% | +4.9% | +57.3% | -3.7% | +29.9% | +22.7% | +15.8% | +77.5% | -15.6% | -21.5% | +42.6% |